RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults | MicrobiomeTrials← Back to trialsNCT07816471
RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults
RecruitingOBSERVATIONAL
Trial Details
Start: 2011-11-01Est. Completion: 2025-12-31
Enrollment target: 350 participants Other microbiome trials you might be interested in
ImmunityRespiratory InfectionAsthma
This prospective observational study will enroll approximately 1,200 children from birth through 7 years of age in Zheji…
Dongyang, ChinaEst. completion Dec 31, 2036
Respiratory Syncytial Virus (RSV)
A Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection
Anning, ChinaEst. completion Jul 1, 2028